Skip to main content
OpenTrials

Clinical trial condition

Higher-risk Myelodysplastic Syndromes

Explore clinical trials studying Higher-risk Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

3 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Higher-risk Myelodysplastic Syndromes trial results

Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

NCT07155226

Conditions
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Bone Marrow Diseases, +15 more
Locations
  • Research Site Decatur, Illinois, United States
  • Research Site New York, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Durham, North Carolina, United States
View all 30 locations
View Trial Details
Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

NCT06196203

Conditions
Higher-risk Myelodysplastic Syndromes
Locations
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mid Florida Hematology and Oncology Center Orange City, Florida, United States
View all 15 locations
View Trial Details

Related conditions